Gut-immune signaling drives blood-brain barrier damage in pediatric allogeneic stem cell transplant
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a life-saving therapy for children with high-risk hematological diseases. However, allo-HSCT also confers the risk of long-term neurocognitive dysfunction, particularly in pediatric recipients, and the mechanisms underlying this remain poorly understood. While gastrointestinal toxicities and immune responses following allo-HSCT…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
